Sophie Snitkovsky - Publications
Affiliations: | 2000 | Harvard University, Cambridge, MA, United States |
Year | Citation | Score | |||
---|---|---|---|---|---|
2002 | Snitkovsky S, Young JA. Targeting retroviral vector infection to cells that express heregulin receptors using a TVA-heregulin bridge protein. Virology. 292: 150-5. PMID 11878917 DOI: 10.1006/Viro.2001.1314 | 0.828 | |||
2001 | Snitkovsky S, Niederman TM, Mulligan RC, Young JA. Targeting avian leukosis virus subgroup A vectors by using a TVA-VEGF bridge protein. Journal of Virology. 75: 1571-5. PMID 11152532 DOI: 10.1128/Jvi.75.3.1571-1575.2001 | 0.809 | |||
2000 | Snitkovsky S, Niederman TM, Carter BS, Mulligan RC, Young JA. A TVA-single-chain antibody fusion protein mediates specific targeting of a subgroup A avian leukosis virus vector to cells expressing a tumor-specific form of epidermal growth factor receptor. Journal of Virology. 74: 9540-5. PMID 11000224 DOI: 10.1128/Jvi.74.20.9540-9545.2000 | 0.792 | |||
1999 | Boerger AL, Snitkovsky S, Young JA. Retroviral vectors preloaded with a viral receptor-ligand bridge protein are targeted to specific cell types. Proceedings of the National Academy of Sciences of the United States of America. 96: 9867-72. PMID 10449786 DOI: 10.1073/Pnas.96.17.9867 | 0.303 | |||
1998 | Snitkovsky S, Young JA. Cell-specific viral targeting mediated by a soluble retroviral receptor-ligand fusion protein. Proceedings of the National Academy of Sciences of the United States of America. 95: 7063-8. PMID 9618539 DOI: 10.1073/Pnas.95.12.7063 | 0.78 | |||
Show low-probability matches. |